Cisplatin and Etoposide for Metastatic Testis Cancer in a Renal Transplant Recipient
- 1 June 1990
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 143 (6) , 1235-1236
- https://doi.org/10.1016/s0022-5347(17)40237-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol.Journal of Clinical Oncology, 1989
- A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.Journal of Clinical Oncology, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Whither carboplatin?--A replacement for or an alternative to cisplatin?Journal of Clinical Oncology, 1987
- Curative, platinum-based cytoxic drug therapy in a renal transplant recipient with metastatic testicular cancerCancer, 1986
- Circadian time dependence of cisplatin urinary kineticsClinical Pharmacology & Therapeutics, 1982
- Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular CancerAnnals of Internal Medicine, 1981
- Vinblastine, bleomycin and cis-diamminedichloroplatinum in the treatment of advanced testicular carcinoma: Possible importance of longer induction and shorter maintenance schedulesThe American Journal of Medicine, 1980
- Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in manCancer, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977